HU169193B - - Google Patents

Info

Publication number
HU169193B
HU169193B HUEI573A HUEI000573A HU169193B HU 169193 B HU169193 B HU 169193B HU EI573 A HUEI573 A HU EI573A HU EI000573 A HUEI000573 A HU EI000573A HU 169193 B HU169193 B HU 169193B
Authority
HU
Hungary
Application number
HUEI573A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU169193B publication Critical patent/HU169193B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
HUEI573A 1973-11-05 1974-11-04 HU169193B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (1)

Publication Number Publication Date
HU169193B true HU169193B (hu) 1976-10-28

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
HUEI573A HU169193B (hu) 1973-11-05 1974-11-04

Country Status (26)

Country Link
US (1) US3968125A (hu)
JP (1) JPS6033835B2 (hu)
AR (1) AR202318A1 (hu)
AT (1) AT336012B (hu)
BE (1) BE821716A (hu)
BG (1) BG26387A3 (hu)
CA (1) CA1023753A (hu)
CH (1) CH605894A5 (hu)
CS (1) CS193507B2 (hu)
DD (1) DD116230A5 (hu)
DE (1) DE2451934C2 (hu)
DK (1) DK136719B (hu)
ES (1) ES431674A1 (hu)
FR (1) FR2249664B1 (hu)
GB (1) GB1487637A (hu)
HU (1) HU169193B (hu)
IE (1) IE40023B1 (hu)
IL (1) IL45644A (hu)
NL (1) NL7414439A (hu)
PH (1) PH11788A (hu)
PL (2) PL95748B1 (hu)
RO (1) RO71766A (hu)
SE (1) SE415762B (hu)
SU (1) SU524517A3 (hu)
YU (1) YU36515B (hu)
ZA (1) ZA745751B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (hu) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
US20050101590A1 (en) 2002-02-19 2005-05-12 Kiyoshi Yasui Antipruritics
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2176208B1 (en) * 2007-07-30 2015-01-21 Zynerba Pharmaceuticals, Inc. Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
EP2254601B1 (en) 2008-02-08 2019-05-29 Nektar Therapeutics Oligomer-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20200197357A1 (en) 2017-07-20 2020-06-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods of lipophilic drugs
WO2019049145A1 (en) 2017-09-11 2019-03-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. COMPOSITIONS AND METHODS FOR NASAL BRAIN MEDICATION ADMINISTRATION FOR SYSTEMIC EFFECT
EP3717014A1 (en) 2017-11-29 2020-10-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Cannabinoids compositions and methods
WO2020089905A1 (en) 2018-11-04 2020-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
ES431674A1 (es) 1976-11-16
DE2451934A1 (de) 1975-05-07
SU524517A3 (ru) 1976-08-05
NL7414439A (nl) 1975-05-07
CS193507B2 (en) 1979-10-31
ATA886374A (de) 1976-08-15
IE40023B1 (en) 1979-02-28
DK136719C (hu) 1978-04-24
IL45644A0 (en) 1974-11-29
PL95748B1 (pl) 1977-11-30
FR2249664A1 (hu) 1975-05-30
DK136719B (da) 1977-11-14
PH11788A (en) 1978-07-05
IE40023L (en) 1975-05-05
RO71766A (ro) 1982-12-06
GB1487637A (en) 1977-10-05
BG26387A3 (bg) 1979-03-15
JPS6033835B2 (ja) 1985-08-05
US3968125A (en) 1976-07-06
SE7413833L (hu) 1975-05-06
CH605894A5 (hu) 1978-10-13
BE821716A (fr) 1975-04-30
ZA745751B (en) 1976-04-28
DD116230A5 (hu) 1975-11-12
CA1023753A (en) 1978-01-03
AU7321274A (en) 1976-03-18
YU265874A (en) 1982-02-25
DE2451934C2 (de) 1983-10-06
DK573274A (hu) 1975-07-07
SE415762B (sv) 1980-10-27
AR202318A1 (es) 1975-05-30
AT336012B (de) 1977-04-12
PL93908B1 (hu) 1977-07-30
YU36515B (en) 1984-02-29
FR2249664B1 (hu) 1978-03-24
JPS5071678A (hu) 1975-06-13
IL45644A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
AR201758A1 (hu)
AU476761B2 (hu)
AU465372B2 (hu)
AR201235Q (hu)
AR201231Q (hu)
AU474593B2 (hu)
AU474511B2 (hu)
FR2249664B1 (hu)
AU474838B2 (hu)
AU471343B2 (hu)
AU465453B2 (hu)
AU465434B2 (hu)
AU450229B2 (hu)
AU476714B2 (hu)
AR201229Q (hu)
AU466283B2 (hu)
AU476696B2 (hu)
AU472848B2 (hu)
AR199451A1 (hu)
AU477823B2 (hu)
AR200256A1 (hu)
AR200885A1 (hu)
AU476873B1 (hu)
AR195948A1 (hu)
AR201432A1 (hu)